International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2018, Vol 6, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Case Report
Uterine Leiomyosarcoma: A Case Report
Forough Forghani¹, Abolfazl Mehdizadeh Kashi², Kambiz Sadegi^3,4, Mania Kaveh^2,1, Mehrangiz Ghafari⁵
¹Department of Obstetrics and Gynecology, Zabol University of Medical Sciences, Zabol, Iran ²Endometriosis and Gynecological Disorder Research Center, Iran University of Medical Sciences, Tehran, Iran ³Pain Research Center, Iran University of Medical Sciences, Tehran, Iran ⁴Department of Anesthesiology, Zabol University of Medical Sciences, Zabol, Iran ⁵Department of Pathology, Zabol University of Medical Sciences, Zabol, Iran
IJWHR 2018; 6: 390-392 DOI: 10.15296/ijwhr.2018.64 Viewed : 2870 times Downloaded : 2690 times. Keywords : Uterine leiomyosarcoma, Gynecologic oncologist
Full Text(PDF) \| Related Articles
Abstract

Objectives: Uterine leiomyosarcoma (LMS) is a rare cancer originated from smooth muscle lining the walls of the uterus. LMS is known as an aggressive tumor with high mortality and morbidity rates compared to other uterine cancers, despite the disease stage at the time of diagnosis. In most cases, LMS has been misdiagnosed as benign uterine leiomyoma following hysterectomy or myomectomy. Case Presentation: We present a 53-year-old G7 L7 woman who was referred to our clinic for abnormal uterine bleeding (AUB) for 6 months. On physical examination, we found an abdominal mass that had grown rapidly in the last 4 months. The computed tomography (CT) scan results showed a heterogeneous mass extending from the epigastric region to the pelvic area. Following an exploratory laparotomy, histopathology report confirmed the diagnosis of LMS. Her uterus, Fallopian tubes and ovaries were removed during a surgery, and she was referred to a gynecologic oncologist for possible chemotherapy. Conclusions: We found that the surgery was the only treatment for LMS. Although there is a faint possibility to diagnose LMS before surgery, in the patient with uncertain diagnosis and suspicious of LMS, analysis of LDH and LDH3 levels along with dynamic gadolinium- diethylenetriamine penta-acetic acid (Gd-DTPA) enhanced magnetic resonance imaging (MRI) is recommended.